Last edition
News about
Syntegon Showcases New Settle Plate Changer at ACHEMA 2024
Syntegon has showcased an important new development at ACHEMA 2024 that generated a great deal of interest among pharmaceutical manufacturers: the patented Settle Plate Changer (SPC) for automated viable monitoring in the aseptic filling process.
Sun Pharmaceutical Industries and Moebius Medical have presented data demonstrating the durability of pain relief achieved in symptomatic knee OA patients through 26 weeks post injection of MM-II.
Takeda Signs Option Deal with Ascentage Pharma to Get Exclusive Global License for Olverembatinib
Takeda has signed an option agreement with Ascentage Pharma to enter into an exclusive license agreement for olverembatinib, an oral, potentially best-in-class, third-generation BCR-ABL tyrosine kinase inhibitor.
Glenmark Gets ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules
Glenmark has secured final approval by the United States Food & Drug Administration (US FDA) for Esomeprazole Magnesium Delayed-Release Capsules.
Great Point Partners Announces Acquisition of Lyocontract
Great Point Partners (GPP) has acquired Lyocontract GmbH (Lyocontract), a premium independent drug product contract development and manufacturing organization (CDMO) based in Ilsenburg, Germany.
Novavax Submits Application to FDA for Updated JN.1 COVID-19 Vaccine
Novavax, Inc. has submitted an amendment to its Emergency Use Authorization to the US Food and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine (NVX-CoV2705) for individuals aged 12 and older.
SS Innovations Launches Advanced SSI Mantra 3 Robotic System
SS Innovations launched SSI Mantra 3, which is the next generation, most advanced version of the Mantra surgical robot system.
USFDA Grants Approval to Ipsen and Genfit's Drug to Treat Chronic Inflammatory Liver Disease
The French pharmaceutical companies Ipsen and Genfit received fast approval from the US Food and Drug Administration (USFDA) for their medication to treat chronic inflammatory liver disease.
Akums Launches Rabeprazole + Levosulpiride SR Capsules
Akums Akums Drugs & Pharmaceuticals Ltd. announced that it has launched Rabeprazole + Levosulpiride SR Capsules. Approved by the Drug Controller General of India (DCGI), the company claims this new formulation aims to enhance relief for patients suffering from gastrointestinal tract (GIT) disorders.
Bio-Sourcing and Afrigen Biologics to Accelerate Biomanufacturing in South Africa
Bio-Sourcing has signed a partnership agreement with Afrigen Biologics to develop a pilot program in South Africa of a groundbreaking biotherapeutic platform, BioMilk.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy